Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM8Z8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,191
Award facts
- Contract value 100% obligated
- $64,190.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $64,190.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pens on January 6, 2026, with completion expected by January 7, 2026. The award covers pharmaceutical delivery to the place of performance in Conshohocken, Pennsylvania, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
Cosentyx is a specialty biologic medication used primarily for autoimmune and inflammatory conditions. As a pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has established itself as a critical vendor for federal medical procurement through its extensive contract portfolio with the DLA and other government healthcare systems, including the Defense Health Agency and Department of Veterans Affairs. The company's federal contract awards demonstrate consistent capability in delivering brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains in support of military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM8Z8?
SPE2DR26FM8Z8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FM8Z8 worth?
The government has obligated $64,191 on SPE2DR26FM8Z8.
Is contract SPE2DR26FM8Z8 an order under another contract?
Yes. SPE2DR26FM8Z8 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM8Z8 competed?
The extent of competition for SPE2DR26FM8Z8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award